Acute dosing of latrepirdine (Dimebon™), a possible Alzheimer therapeutic, elevates extracellular amyloid-β levels in vitro and in vivo

Overview of attention for article published in Molecular Neurodegeneration, December 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

blogs: 1 blog

f1000: 1 research highlight platform

Citations

dimensions_citation: 40 Dimensions

Readers on

mendeley: 54 Mendeley
connotea: 1 Connotea

Summary Blogs Research highlights Dimensions citations

So far, Altmetric has seen 1 blog post.

Pfizer's New Alzheimer's Drug: A Black Box Indeed

SeekingAlpha Biotech Stocks, 04 Feb 2010

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.